Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3

Cell Proliferation

Volumn 32, Issue 1, 1999, Pages 63-73

  Ido, Y ^a   Muto, N ^b   Inada, A ^c   Kohroki, J ^a   Mano, M ^a   Odani, T ^a   Itoh, N ^a   Yamamoto, K ^d   Tanaka, K ^a  

^a OSAKA UNIVERSITY   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^c SETSUNAN UNIVERSITY   (Japan)

^d Gen Test Res Inst Japan O   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA FRAGMENT; IRON CHELATING AGENT; THUJAPLICIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FREE SYSTEM; CELL NUCLEUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; EMBRYO; ENZYME ACTIVATION; MOUSE; NONHUMAN; TERATOCARCINOMA;

AMINO ACID CHLOROMETHYL KETONES; ANILINE COMPOUNDS; APOPTOSIS; CASPASE 3; CASPASES; CELL-FREE SYSTEM; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; ENZYME ACTIVATION; IRON CHELATING AGENTS; MONOTERPENES; OLIGOPEPTIDES; TERATOCARCINOMA; TROPOLONE; TUMOR STEM CELLS;

EID: 0032932808     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1999.00133.x     Document Type: Article

References (40)

1. ANJUM R, KHAR A. (1997) Caspase-mediated apoptosis in AK-5 tumor cells: a cell-free study using peptide inhibitors and antisense strategy. Exp. Cell Res. 236, 371.
2. BERSTINE EG, HOOPER ML, GRANDCHAMP S, EPHRUSSI B. (1973) Alkaline phosphatase activity in mouse teratoma. Proceedings Natl. Acad. Sci. USA 70, 3899.
3. BRYANT BE, FERNELIUS WC, DOUGLAS BE. (1953) Formation constants of metal complexes of tropolone and its derivatives. I. Tropolone. J. Am. Chem. Soc. 75, 3784.
4. BURTON K. (1968) Determination of DNA concentration with diphenylamine. In: Grossman L, Moldave K, eds. Methods in Enzymol. 12B. New York: Academic Press, 163.
5. CHITAMBAR CR, NARASIMHAN J, GUY J, SEM DS, O'BRIEN WJ. (1991) Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells. Cancer Res. 51, 6199.
6. DATTA R, BANACH D, KOJIMA H et al. (1996) Activation of the CPP. 32 protease in apoptosis induced by 1-beta-d-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88, 1936.
7. DATTA R, KOJIMA H, BANACH D et al. (1997) Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J. Biol. Chem. 272, 1965.
8. DOI T, SUMI T, NISHINA Y et al. (1995) Induction of teratocarcinoma F9 cell differentiation with cis-diammine dichloroplatinum (II) (CDDP). Cancer Lett. 88, 81.
9. ENARI M, HASE A, NAGATA S. (1995) Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14, 5201.
10. ENARI M, SAKAHIRA H, YOKOYAMA H, OKAWA K, IWAMATSU A, NAGATA S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43.
11. GOLSTEIN P. (1997) Controlling cell death. Science 275, 1081.
12. GURTU V, KAIN SR, ZHANG G. (1997) Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal. Biochem. 251, 98.
13. HAQ RU, WERELEY JP, CHITAMBAR CR. (1995) Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. Exp. Hematol. 23, 428.
14. HILETI D, PANAYIOTIDIS P, HOFFBRAND AV. (1995) Iron chelators induce apoptosis in proliferating cells. Br. J. Haematol. 89, 181.
15. HIRSCH T, MARCHETTI P, SUSIN SA et al. (1997) The apoptosis-necrosis paradox. Apoptogenic proteinase activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573.
16. HOGAN BLM, TAYLOR A, ADAMSON E. (1981) Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm. Nature 291, 235.
17. KLUCK RM, MARTIN SJ, HOFFMAN BM, ZHOU JS, GREEN DR, NEWMEYER DD. (1997) Cytochrome c activation of CPP. 32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16, 4639.
18. KROEMER G. (1997) Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Dif. 4, 443.
19. LEDERMAN HM, COHEN A, LEE JWW, FREEDMAN MH, GELFAND EW. (1984) Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood 64, 748.
20. LIU X, KIM CN, YANG J, JEMMERSON R, WANG X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 86, 147.
21. LIU X, ZOU H, SLAUGHTER C, WANG X. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175.
22. MARCHETTI P, CASTEDO M, SUSIN SA et al. (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184, 1155.
23. MCCUE PA, GUBLER ML, SHERMAN MI, COHEN BN. (1984) Sodium butyrate induces histone hyperacetylation and differentiation of murine embryonal carcinoma cells. J. Cell Biol. 98, 602.
24. MUTO N, DOTA A, TANAKA T et al. (1995) Hinokitiol induces differentiation of teratocarcinoma F9 cells. Biol. Pharm. Bull. 18, 1576.
25. NEWMEYER DD, FARSCHON DM, REED JC. (1994) Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353.
26. NISHIMUNE Y, . KUME A, OGISO Y, MATSUSHIRO A. (1983) Induction of teratocarcinoma cell differentiation. Effect of the inhibitors of DNA synthesis. Exp. Cell Res. 146, 439.
27. SAKAHIRA H, ENARI M, NAGATA S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96.
28. SHAO RG, SHIMIZU T, POMMIER Y. (1997) 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. Exp. Cell Res. 234, 388.
29. SHIMIZU T, POMMIER Y. (1996) DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies. Exp. Cell Res. 226, 292.
30. SHIMIZU T, POMMIER Y. (1997) Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteinase. Leukemia 11, 1238.
31. STRICKLAND S, SMITH KK, MOROTTI KR. (1980) Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21, 347.
32. SUSIN SA, ZAMZAMI N, CASTEDO M et al. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331.
33. TANAKA T, MUTO N, IDO Y, ITOH N, TANAKA K. (1997) Induction of embryonal carcinoma cell differentiation by deferoxamine, a potent therapeutic iron chelator. Biochim. Biophys. Acta 1357, 91.
34. TANAKA T, MUTO N et al. (1995) Induction of differentiation of embryonal carcinoma F9 cells by iron chelators. Res. Commun. Mol. Pathol. Pharmacol. 90, 211.
35. YAMATO M, HASHIGAKI K, KOKUBU N, NAKATO Y. (1984) Synthesis of tropolone derivatives. J. Chem. Soc. Perkin Trans. I, 1301.
36. YANG J, LIU X, BHALLA K et al. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129.
37. YOSHIDA A, TAKAUJI R, INUZUKA M, UEDA T, NAKAMURA T. (1996) Role of serine and ICE-like proteinase in induction of apoptosis by etoposide in human leukemia HL-60 cells. Leukemia 10, 821.
38. ZAMZAMI N, HIRSCH T, DALLAPORTA B, PETIT PX, KROEMER G. (1997) Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29, 185.
39. ZAMZAMI N, MARCHETTI P, CASTEDO M et al. (1996b) Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384, 53.
40. ZAMZAMI N, SUSIN SA, MARCHETTI P et al. (1996a) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533.